Phyllis McKiernan
Adult Health · Hackensack, NJNPI 1194939652
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Sanofi-aventis U.S. LLC accounts for 81.2% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $20,575, 9.6 times the $2,150 reported in 2021. Among adult health clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 281 payments — averaging $256.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$59K
- Incyte Corporation$4K
- Pharmacosmos Therapeutics Inc.$3K
- Legend Biotech USA Inc.$2K
- Kadmon Pharmaceuticals LLC$2K
- Astellas Pharma US Inc$371
- plus $2K from 22 others
What the payments were for
- Consulting fees$8,06011%
- Speaking & faculty fees$38,73654%
- Travel & lodging$19,06226%
- Food & beverage$5,8578%
- Education$3661%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 145 | $58,552 |
| Incyte Corporation | 18 | $4,495 |
| Pharmacosmos Therapeutics Inc. | 7 | $2,717 |
| Legend Biotech USA Inc. | 16 | $1,997 |
| Kadmon Pharmaceuticals LLC | 2 | $1,928 |
| Astellas Pharma US Inc | 12 | $371 |
| E.r. Squibb & Sons, L.L.C. | 9 | $291 |
| Johnson & Johnson | 10 | $226 |
| Daiichi Sankyo Inc. | 8 | $223 |
| AstraZeneca(2 entities) | 4 | $173 |
| Merck | 9 | $161 |
| Jazz Pharmaceuticals Inc. | 1 | $150 |
| Bristol Myers Squibb | 8 | $146 |
| GSK | 1 | $109 |
| Taiho Oncology, Inc. | 5 | $87 |
| Novartis | 4 | $78 |
| Sanofi | 4 | $71 |
| Geron Corporation | 3 | $53 |
| AbbVie | 3 | $46 |
| Eisai Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Immunocore Limited | 2 | $33 |
| Adaptive Biotechnologies Corporation | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Genmab U.S., Inc. | 1 | $16 |
| CTI Biopharma Corp. | 1 | $15 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$72,082 in reported general payments places this provider in the 95th percentile of 1,135 adult health providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RezurockBelumosudil Mesylate | 54 | $1,127,845 |
| Posaconazole | 14 | $18,330 |
| OxycontinOxycodone Hcl | 11 | $8,925 |
| ValacyclovirValacyclovir Hcl | 71 | $2,741 |
| Fluconazole | 11 | $384 |
| Oxycodone Hcl | 20 | $256 |
| Diltiazem Hcl | 18 | $226 |
| Rosuvastatin Calcium | 15 | $222 |
| Celecoxib | 14 | $203 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 42 | $194 |
| Escitalopram Oxalate | 13 | $193 |
| Pantoprazole Sodium | 26 | $152 |
| Famotidine | 14 | $129 |
| Prednisone | 13 | $113 |
| Amlodipine Besylate | 14 | $41 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sanofi-aventis U.S. LLCRezurock | $58,552 | $1,127,84554 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,135 adult health providers in New Jersey.
Other adult health in Hackensack
- June HalperHackensack$358K
- Samantha DepadovaHackensack$34K
- Pamela SutherlandHackensack$22K
- Rosemarie WellmanHackensack$9K
- Derrick RodriguezHackensack$8K
- Susan KumkaHackensack$8K
- Caroline KozekHackensack$7K
- Rey PellaHackensack$6K
- Kara SaggiomoCamden$127K
- Entela AhmetiPomona$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.